Cargando…

Cannabis-based product use in a multiple sclerosis cohort

OBJECTIVE: The objective of this study was to characterize the use of cannabis-based products (CBPs) by multiple sclerosis (MS) patients who attend the University of British Columbia Hospital (UBCH) MS clinic. METHODS: All patients attending the UBCH MS clinic from January to March 2018 were invited...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schabas, AJ, Vukojevic, V, Taylor, C, Thu, Z, Badyal, A, Chan, JK, Devonshire, V, Traboulsee, A, Sayao, AL, Carruthers, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764052/ https://www.ncbi.nlm.nih.gov/pubmed/31598330 http://dx.doi.org/10.1177/2055217319869360

Ejemplares similares

Cervical cord myelin abnormality is associated with clinical disability in multiple sclerosis
por: Lee, Lisa Eunyoung, et al.
Publicado: (2021)

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort
por: Cross, Helen, et al.
Publicado: (2021)

Preliminary testing of a patient decision aid for patients with relapsing-remitting multiple sclerosis
por: Bansback*, Nick, et al.
Publicado: (2021)

Development and usability testing of a patient decision aid for newly diagnosed relapsing multiple sclerosis patients
por: Bansback, Nick, et al.
Publicado: (2019)

Associations Between Findings From Myelin Water Imaging and Cognitive Performance Among Individuals With Multiple Sclerosis
por: Abel, Shawna, et al.
Publicado: (2020)

The road to conception for women with multiple sclerosis
por: Sadovnick, Dessa, et al.
Publicado: (2021)

The Canadian prospective cohort study to understand progression in multiple sclerosis (CanProCo): rationale, aims, and study design
por: Oh, Jiwon, et al.
Publicado: (2021)

Cervical Spinal Cord Atrophy can be Accurately Quantified Using Head Images
por: Taheri, Kamyar, et al.
Publicado: (2022)

Case of alemtuzumab-related alopecia areata management in MS
por: Chan, Jillian K., et al.
Publicado: (2018)

Cannabis and Multiple Sclerosis—The Way Forward
por: Rudroff, Thorsten, et al.
Publicado: (2017)

Short-term outcomes of pediatric multiple sclerosis patients treated with alemtuzumab at a Canadian University multiple sclerosis clinic
por: Jure Hunt, David, et al.
Publicado: (2020)

Machine learning in secondary progressive multiple sclerosis: an improved predictive model for short-term disability progression
por: Law, Marco TK, et al.
Publicado: (2019)

The Efficacy of Cannabis on Multiple Sclerosis-Related Symptoms
por: Haddad, Fatma, et al.
Publicado: (2022)

Accounting for uncertainty in training data to improve machine learning performance in predicting new disease activity in early multiple sclerosis
por: Tayyab, Maryam, et al.
Publicado: (2023)

Standardized cannabis in multiple sclerosis: a case report
por: Hornby, Paul, et al.
Publicado: (2010)

Cannabis and cognitive functioning in multiple sclerosis: The role of gender
por: Patel, Viral P, et al.
Publicado: (2017)

Quantifying visual pathway axonal and myelin loss in multiple sclerosis and neuromyelitis optica
por: Manogaran, Praveena, et al.
Publicado: (2016)

Neonatal and Delivery Outcomes in Women with Multiple Sclerosis
por: van der Kop, Mia L, et al.
Publicado: (2011)

Multiple sclerosis, cannabis, and cognition: A structural MRI study
por: Romero, Kristoffer, et al.
Publicado: (2015)

The Effect of Cannabis on the Clinical and Cytokine Profiles in Patients with Multiple Sclerosis
por: Mustafa, Wessam, et al.
Publicado: (2021)

Application of pharmacogenomics to investigate adverse drug reactions to the disease-modifying treatments for multiple sclerosis: a case–control study protocol for dimethyl fumarate-induced lymphopenia
por: Kowalec, Kaarina, et al.
Publicado: (2017)

Cervical cord myelin water imaging shows degenerative changes over one year in multiple sclerosis but not neuromyelitis optica spectrum disorder
por: Combes, Anna J.E., et al.
Publicado: (2017)

Perspectives on Cannabis-Based Therapy of Multiple Sclerosis: A Mini-Review
por: Mecha, Miriam, et al.
Publicado: (2020)

Cannabis for Neuropathic Pain in Multiple Sclerosis—High Expectations, Poor Data
por: Rudroff, Thorsten
Publicado: (2019)

Monitoring and management of autoimmunity in multiple sclerosis patients treated with alemtuzumab: practical recommendations
por: Devonshire, Virginia, et al.
Publicado: (2018)

Quantitative MRI findings indicate diffuse white matter damage in Susac Syndrome
por: Johnson, P, et al.
Publicado: (2022)

Adherence to interferon β-1a therapy using an electronic self-injector in multiple sclerosis: a multicentre, single-arm, observational, phase IV study
por: Devonshire, Virginia A., et al.
Publicado: (2016)

Productivity loss among people with early multiple sclerosis: A Canadian study
por: Rodriguez Llorian, Elisabet, et al.
Publicado: (2022)

Employment status, productivity loss, and associated factors among people with multiple sclerosis
por: Rodriguez Llorian, Elisabet, et al.
Publicado: (2023)

Personalized activity index, a new safety monitoring tool for multiple sclerosis clinical trials
por: Zhao, Yinshan, et al.
Publicado: (2015)

Improving the clinical correlation of multiple sclerosis black hole volume change by paired-scan analysis()
por: Tam, Roger C., et al.
Publicado: (2012)

Cortical morphology predicts placebo response in multiple sclerosis
por: Cherkasova, Mariya V., et al.
Publicado: (2022)

Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review
por: Lakhan, Shaheen E, et al.
Publicado: (2009)

Reduction in magnetic resonance imaging T2 burden of disease in patients with relapsing-remitting multiple sclerosis: analysis of 48-week data from the EVIDENCE (EVidence of Interferon Dose-response: European North American Comparative Efficacy) study
por: Traboulsee, A, et al.
Publicado: (2008)

Models of Care in Multiple Sclerosis: A Survey of Canadian Health Providers
por: Marrie, Ruth Ann, et al.
Publicado: (2022)

Both Stationary and Dynamic Functional Interhemispheric Connectivity Are Strongly Associated With Performance on Cognitive Tests in Multiple Sclerosis
por: Lin, Sue-Jin, et al.
Publicado: (2020)

Impaired awareness: Why people with multiple sclerosis continue using cannabis despite evidence to the contrary
por: Feinstein, Anthony, et al.
Publicado: (2021)

Myelin water imaging in relapsing multiple sclerosis treated with ocrelizumab and interferon beta-1a
por: Kolind, Shannon, et al.
Publicado: (2022)

Quantitative neuroimaging measures of myelin in the healthy brain and in multiple sclerosis
por: O'Muircheartaigh, Jonathan, et al.
Publicado: (2019)

Error in key model input
por: Schabas, Richard
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_368jmcl2025eld7jgdhdbv8r3a